Syndax Pharmaceuticals’ (SNDX) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a report published on Tuesday morning,Benzinga reports. HC Wainwright currently has a $51.00 price objective on the stock. HC Wainwright also issued estimates for Syndax Pharmaceuticals’ Q1 2025 earnings at ($1.00) EPS, Q2 2025 earnings at ($0.98) EPS, Q3 […]
HC Wainwright restated their buy rating on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a report published on Tuesday morning,Benzinga reports. HC Wainwright currently has a $51.00 price objective on the stock. HC Wainwright also issued estimates for Syndax Pharmaceuticals’ Q1 2025 earnings at ($1.00) EPS, Q2 2025 earnings at ($0.98) EPS, Q3 […]
